{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T15:48:53Z","timestamp":1786808933827,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Hemophagocytic lymphohistiocytosis (HLH) is a rare life-threatening disease. Initial therapy is based on etoposide, dexamethasone, and cyclosporine (CSA). The pharmacokinetics (PKs) of CSA and other drugs are sometimes altered in patients with HLH complicated by diabetes insipidus (DI) but the precise mechanisms remain unknown.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>In this study, the authors present a case of a 4-year-old boy with HLH complicated by DI. CSA concentrations were determined by enzyme multiplied immunoassay technique; noncompartmental PK analysis of the plasma concentration\u2013time data was performed using PKSolver; and linear regression analysis was performed to determine linearity of relationship between urine output and C<jats:sub>0<\/jats:sub> levels of CSA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Although C<jats:sub>0<\/jats:sub> values of CSA were lower than the target levels, the patient was successfully treated and a good clinical outcome was achieved. Linear regression analysis showed a strong negative correlation between urine output and the serum trough concentration (C<jats:sub>0<\/jats:sub>) of CSA, pharmacokinetic analysis showed the main PK parameters of CSA as follows: C<jats:sub>0<\/jats:sub>, 50.2 mcg\/L; peak concentration (C<jats:sub>max<\/jats:sub>), 723.4 mcg\/L; area under the curve<jats:sub>0\u201324<\/jats:sub>, 7478.2 mcg\u00b7h\/L; clearance, 0.77 L\/h\/kg, elimination half-life, 5.3 hours, and volume of distribution, 6.0 L\/kg.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>To the best of the authors' knowledge, this is the first report of the CSA PK profile in a patient with HLH complicated by DI. The authors suppose that a large fluid output and input leads to extensive CSA distribution. These results suggest that the monitoring of the C<jats:sub>max<\/jats:sub> and area under the curve of CSA might be more clinically and pharmacokinetically significant than that of C<jats:sub>0<\/jats:sub> in patients with HLH complicated by DI. This case highlights the importance of therapeutic drug monitoring and demonstrates PK parameters of CSA in a pediatric patient with HLH complicated by DI.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000000875","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T20:49:49Z","timestamp":1613940589000},"page":"303-306","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic Drug Monitoring and Pharmacokinetic Analysis of Cyclosporine in a Pediatric Patient with Hemophagocytic Lymphohistiocytosis Complicated by Diabetes Insipidus: A Grand Round"],"prefix":"10.1097","volume":"43","author":[{"given":"Yujian","family":"Liang","sequence":"first","affiliation":[{"name":"Department of Pediatric Intensive Care Unit, The First Affiliated Hospital, Sun Yat-Sen University; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyi","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care Unit, The First Affiliated Hospital, Sun Yat-Sen University; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R2-20250603","first-page":"1176","article-title":"US consensus guidelines for the use of cyclosporin A in rheumatoid arthritis","volume":"26","author":"Cush","year":"1999","journal-title":"J Rheumatol."},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1345\/aph.1P588","article-title":"Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients","volume":"45","author":"Eiland","year":"2011","journal-title":"Ann Pharmacother."},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1097\/INF.0b013e318286378e","article-title":"Improved vancomycin dosing in children using area under the curve exposure","volume":"32","author":"Le","year":"2013","journal-title":"Pediatr Infect Dis J."},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/cid\/ciaa303","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"71","author":"Rybak","year":"2020","journal-title":"Clin Infect Dis."},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/ped.13064","article-title":"Hemophagocytic lymphohistiocytosis: pathogenesis, diagnosis, and management","volume":"58","author":"Morimoto","year":"2016","journal-title":"Pediatr Int."},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis."},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/ptr.4849","article-title":"Effect of Wuzhi tablet (Schisandra sphenanthera extract) on the pharmacokinetics of cyclosporin A in rats","volume":"27","author":"Xue","year":"2013","journal-title":"Phytother Res."},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput Methods Programs Biomed."},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40121-015-0100-z","article-title":"Therapeutic dose monitoring for linezolid in a patient with MRSA pneumonia with bacteremia in diabetes insipidus","volume":"5","author":"Nakamura","year":"2016","journal-title":"Infect Dis Ther."},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/01.TP.0000441097.30094.31","article-title":"Best single time point correlations with AUC for cyclosporine and tacrolimus in HIV-infected kidney and liver transplant recipients","volume":"97","author":"Frassetto","year":"2014","journal-title":"Transplantation"},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/bdd.1967","article-title":"Therapeutic drug monitoring of cyclosporine and area under the curve prediction using a single time point strategy: appraisal using peak concentration data","volume":"36","author":"Srinivas","year":"2015","journal-title":"Biopharm Drug Dispos"},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1399-3046.2008.00968.x","article-title":"Pharmacokinetic monitoring of intravenous cyclosporine A in pediatric stem-cell transplant recipients. The trough level is not enough","volume":"13","author":"Schrauder","year":"2009","journal-title":"Pediatr Transpl."},{"issue":"suppl 3","key":"R15-20250603","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transpl."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000875","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:19:17Z","timestamp":1748971157000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000875","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"2020-11-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}